Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
FEMY
#3687
Femasys Inc. Common Stock
0.5
7
0.00%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
0.00%
Changement Mensuel
-3.39%
Evolution sur 6 mois
+50.00%
Changement Annuel
-65.45%
Clôture Précédente
0.5
7
Open
0.5
7
Bid
Ask
Low
0.5
7
High
0.5
7
Volume
5
Marchés
Actions des Marchés US
Soins de Santé
FEMY
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
11.8 M
11.87 M
22.1 M
27.15 M
—
Valuation ratios
Enterprise value
21.25 M
-2.28 M
604.26 K
26.41 M
100.93 M
Price to earnings ratio
-3.48
-0.94
-1.09
-1.29
-4.28
Price to sales ratio
22.19
8.82
14.5
15.04
48.96
Price to cash flow ratio
-3.3
-0.99
-1.38
-1.26
-4.41
Price to book ratio
0.99
0.7
0.85
10.63
14.87
Enterprise value to EBITDA ratio
-2.75
0.21
-0.04
-1.62
-5.92
Profitability ratios
Return on assets %
-0.26
-0.67
-0.51
-1.51
-1.45
Return on equity %
-0.29
-0.75
-0.78
-8.17
-9.14
Return on invested capital %
-929.89
-1 343.28
-1 386.43
-919.33
-721.05
Gross margin %
68.6
63.36
64.54
66.55
253.62
Operating margin %
-706.7
-961.71
-1 353.43
-1 091.75
-3 854.16
EBITDA margin %
-655.02
-913.66
-1 297.16
-1 000.3
-3 459.99
Net margin %
-638.97
-944.62
-1 329.06
-1 155.03
-4 304.57
Liquidity ratios
Quick ratio
15.02
8.96
7.37
0.58
2.14
Current ratio
15.15
9.25
7.59
0.93
3.91
Inventory turnover
1.78
1.37
0.69
0.29
0.2
Asset turnover
0.04
0.05
0.05
0.08
0.15
Solvency ratios
Debt to assets ratio
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
Long term debt to total assets ratio
0
0.01
0.15
0
0.89
Long term debt to total equity ratio
0
0.01
0.23
0
6.98
Per share metrics
Operating cash flow per share
-1.18
-0.91
-0.73
-0.87
-0.7
EBIT per share
-1.24
-0.98
-0.94
-0.8
-0.65
EBITDA per share
-1.15
-0.93
-0.9
-0.73
-0.59
Total debt per share
—
—
—
—
—
Cash per share
3.69
1.1
1.41
0.16
0.53
Net current asset value per share
3.82
1.2
1.51
0.36
1.36
Tangible book value per share
3.92
1.29
1.19
0.1
0.34
Working capital per share
3.57
1.07
1.31
-0.03
-0.05
Book value per share
3.92
1.29
1.19
0.1
0.35
Nouvelles
Femasys receives CPT code approval for infertility treatment
L’action de Femasys augmente suite à un nouveau partenariat de distribution en Suisse
Femasys expands European presence with Swiss distribution deal
Femasys obtient une prolongation de 180 jours du Nasdaq pour se conformer à la règle du prix minimum
Femasys granted 180-day extension by Nasdaq to meet minimum bid price rule
Femasys partners with Refuah Health Center to expand FemaSeed fertility treatment
Jonathan Schechter achète des actions de PharmaCyte Biotech d’une valeur de 48.232€
Jonathan Schechter buys PharmaCyte Biotech shares worth $48,232
Le PDG de Pharmacyte Biotech, Silverman, achète des actions pour 80.000€
Pharmacyte Biotech CEO Silverman buys $80k in shares
Femasys receives FDA clearance for FemVue Controlled diagnostic device
L’action de PharmaCyte Biotech s’envole après la vente réussie de sa participation dans Femasys